FORTALEZA ASSET MANAGEMENT INC/ - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 131 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.

Quarter-by-quarter ownership
FORTALEZA ASSET MANAGEMENT INC/ ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$92,000
-41.0%
5,476
-31.0%
0.75%
-21.3%
Q1 2018$156,000
-3.1%
7,9410.0%0.95%
-6.2%
Q4 2017$161,000
-32.6%
7,941
-42.2%
1.01%
+131.4%
Q3 2017$239,000
+35.8%
13,7310.0%0.44%
+30.8%
Q2 2017$176,000
-1.1%
13,7310.0%0.33%
-7.2%
Q1 2017$178,000
+30.9%
13,7310.0%0.36%
+25.0%
Q4 2016$136,000
-99.9%
13,7310.0%0.29%
+24.1%
Q3 2016$165,870,000
+140467.8%
13,731
+0.8%
0.23%
+139.2%
Q2 2016$118,000
-99.9%
13,626
-2.7%
0.10%
+15.5%
Q1 2016$132,684,000
+54502.5%
14,0110.0%0.08%
-42.9%
Q4 2015$243,000
+113.2%
14,011
+64.6%
0.15%
+83.8%
Q3 2015$114,000
-56.5%
8,514
-26.7%
0.08%
-49.4%
Q2 2015$262,000
+5.6%
11,618
-33.0%
0.16%
+12.9%
Q1 2015$248,000
-40.5%
17,338
-59.9%
0.14%
-26.7%
Q4 2014$417,000
+1.7%
43,200
-4.2%
0.19%
-1.0%
Q3 2014$410,000
+39.5%
45,085
+51.7%
0.19%
+41.9%
Q2 2014$294,000
-37.3%
29,720
-19.5%
0.14%
-43.1%
Q1 2014$469,000
-15.2%
36,9000.0%0.24%
-15.2%
Q4 2013$553,000
+107.1%
36,900
+52.3%
0.28%
+102.9%
Q3 2013$267,00024,2300.14%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders